Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Clinical trial NCT05797246 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05797246
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Diseases Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Neoplasms, Squamous Cell Tumor Virus Infections Infections Virus Diseases DNA Virus Infections Pathologic Processes Disease Attributes Recurrence

Start date: 2023-08-02
Primary completion: 2027-07-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.